POSSIBILITIES FOR CONTROLLING BILATERAL TONIC-CLONIC SEIZURES USING THE APPLICATION EpiTapp® FOR RESISTANT EPILEPSY WITH THE DEVELOPMENT WITH ARTERIOVENOUS MALFORMATION

Patients with drug-resistant epilepsy (DRE) due to an arteriovenous malformation (AVM) located in a functionally significant area of the brain experience a significant decrease in quality of life and require additional non-drug rehabilitation methods aimed at controlling epileptic symptoms. Aim. To present a clinical observation of the use of the Epi-Tapp (R) application in a 29-year-old patient with an AVM. Materials and methods. We used the author's wrist tapping method EpiTapp (R) (RF patent No. 2606489 dated January 10, 2017). Results. Using the EpiTapp (R) application allowed a 29-year-old man with an AVM to reduce the severity and duration of focal seizures in 85% of cases and prevent secondary bilateral transformation of incipient bilateral tonic-clonic seizures in more than 50% of cases. Conclusions. This clinical case demonstrates the possibility of effectively using the EpiTapp (R) application in a patient with drug-resistant epilepsy as an element of a rehabilitation program aimed at controlling epileptic seizures.